BMI is an important determinant of VWF and FVIII levels and bleeding phenotype in patients with von Willebrand disease

Ferdows Atiq, Karin Fijnvandraat, Karin P. M. van Galen, Britta A. P. Laros-van Gorkom, Karina Meijer, Joke de Meris, Michiel Coppens, Eveline P. Mauser-Bunschoten, Marjon H. Cnossen, Johanna G. van der Bom, Jeroen Eikenboom, Frank W. G. Leebeek, WiN study group

Research output: Contribution to journalLetterAcademicpeer-review

Original languageEnglish
Pages (from-to)E201-E205
JournalAmerican Journal of Hematology
Volume94
Issue number8
DOIs
Publication statusPublished - 1 Aug 2019

Cite this

Atiq, F., Fijnvandraat, K., van Galen, K. P. M., Laros-van Gorkom, B. A. P., Meijer, K., de Meris, J., ... WiN study group (2019). BMI is an important determinant of VWF and FVIII levels and bleeding phenotype in patients with von Willebrand disease. American Journal of Hematology, 94(8), E201-E205. https://doi.org/10.1002/ajh.25499
Atiq, Ferdows ; Fijnvandraat, Karin ; van Galen, Karin P. M. ; Laros-van Gorkom, Britta A. P. ; Meijer, Karina ; de Meris, Joke ; Coppens, Michiel ; Mauser-Bunschoten, Eveline P. ; Cnossen, Marjon H. ; van der Bom, Johanna G. ; Eikenboom, Jeroen ; Leebeek, Frank W. G. ; WiN study group. / BMI is an important determinant of VWF and FVIII levels and bleeding phenotype in patients with von Willebrand disease. In: American Journal of Hematology. 2019 ; Vol. 94, No. 8. pp. E201-E205.
@article{4463e038caa4426a8636a3469c29d3e2,
title = "BMI is an important determinant of VWF and FVIII levels and bleeding phenotype in patients with von Willebrand disease",
author = "Ferdows Atiq and Karin Fijnvandraat and {van Galen}, {Karin P. M.} and {Laros-van Gorkom}, {Britta A. P.} and Karina Meijer and {de Meris}, Joke and Michiel Coppens and Mauser-Bunschoten, {Eveline P.} and Cnossen, {Marjon H.} and {van der Bom}, {Johanna G.} and Jeroen Eikenboom and Leebeek, {Frank W. G.} and M. Coppens and A. Kors and S. Zweegman and {de Meris}, J. and Goverde, {G. J.} and Jonkers, {M. H.} and N. Dors and Nijziel, {M. R.} and L. Nieuwenhuizen and K. Meijer and Tamminga, {R. Y. J.} and {van der LindenHagaZiekenhuis}, {P. W.} and Ypma, {P. F.} and Eikenboom, {H. C. J.} and {van der Bom}, {J. G.} and Smiers, {F. J. W.} and B. Granzen and K. Hamuly{\'a}k and P. Brons and {Laros‐van Gorkom}, {B. A. P.} and Leebeek, {F. W. G.} and Cnossen, {M. H.} and F. Atiq and Mauser-Bunschoten, {E. P.} and {van Galen}, {K. P. M.} and F. Atiq and {WiN study group}",
year = "2019",
month = "8",
day = "1",
doi = "10.1002/ajh.25499",
language = "English",
volume = "94",
pages = "E201--E205",
journal = "American Journal of Hematology",
issn = "0361-8609",
publisher = "Wiley-Liss Inc.",
number = "8",

}

Atiq, F, Fijnvandraat, K, van Galen, KPM, Laros-van Gorkom, BAP, Meijer, K, de Meris, J, Coppens, M, Mauser-Bunschoten, EP, Cnossen, MH, van der Bom, JG, Eikenboom, J, Leebeek, FWG & WiN study group 2019, 'BMI is an important determinant of VWF and FVIII levels and bleeding phenotype in patients with von Willebrand disease' American Journal of Hematology, vol. 94, no. 8, pp. E201-E205. https://doi.org/10.1002/ajh.25499

BMI is an important determinant of VWF and FVIII levels and bleeding phenotype in patients with von Willebrand disease. / Atiq, Ferdows; Fijnvandraat, Karin; van Galen, Karin P. M.; Laros-van Gorkom, Britta A. P.; Meijer, Karina; de Meris, Joke; Coppens, Michiel; Mauser-Bunschoten, Eveline P.; Cnossen, Marjon H.; van der Bom, Johanna G.; Eikenboom, Jeroen; Leebeek, Frank W. G.; WiN study group.

In: American Journal of Hematology, Vol. 94, No. 8, 01.08.2019, p. E201-E205.

Research output: Contribution to journalLetterAcademicpeer-review

TY - JOUR

T1 - BMI is an important determinant of VWF and FVIII levels and bleeding phenotype in patients with von Willebrand disease

AU - Atiq, Ferdows

AU - Fijnvandraat, Karin

AU - van Galen, Karin P. M.

AU - Laros-van Gorkom, Britta A. P.

AU - Meijer, Karina

AU - de Meris, Joke

AU - Coppens, Michiel

AU - Mauser-Bunschoten, Eveline P.

AU - Cnossen, Marjon H.

AU - van der Bom, Johanna G.

AU - Eikenboom, Jeroen

AU - Leebeek, Frank W. G.

AU - Coppens, M.

AU - Kors, A.

AU - Zweegman, S.

AU - de Meris, J.

AU - Goverde, G. J.

AU - Jonkers, M. H.

AU - Dors, N.

AU - Nijziel, M. R.

AU - Nieuwenhuizen, L.

AU - Meijer, K.

AU - Tamminga, R. Y. J.

AU - van der LindenHagaZiekenhuis, P. W.

AU - Ypma, P. F.

AU - Eikenboom, H. C. J.

AU - van der Bom, J. G.

AU - Smiers, F. J. W.

AU - Granzen, B.

AU - Hamulyák, K.

AU - Brons, P.

AU - Laros‐van Gorkom, B. A. P.

AU - Leebeek, F. W. G.

AU - Cnossen, M. H.

AU - Atiq, F.

AU - Mauser-Bunschoten, E. P.

AU - van Galen, K. P. M.

AU - Atiq, F.

AU - WiN study group

PY - 2019/8/1

Y1 - 2019/8/1

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85065799268&origin=inward

UR - https://www.ncbi.nlm.nih.gov/pubmed/31037771

U2 - 10.1002/ajh.25499

DO - 10.1002/ajh.25499

M3 - Letter

VL - 94

SP - E201-E205

JO - American Journal of Hematology

JF - American Journal of Hematology

SN - 0361-8609

IS - 8

ER -

Atiq F, Fijnvandraat K, van Galen KPM, Laros-van Gorkom BAP, Meijer K, de Meris J et al. BMI is an important determinant of VWF and FVIII levels and bleeding phenotype in patients with von Willebrand disease. American Journal of Hematology. 2019 Aug 1;94(8):E201-E205. https://doi.org/10.1002/ajh.25499